Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria S Nabaggala"'
Autor:
Agnes Bwanika Naggirinya, Eunice L. Kyomugisha, Maria S. Nabaggala, Benson Nasasira, Josephine Akirana, Elizabeth Oseku, Agnes Kiragga, Barbara Castelnuovo, Rachel L. King, Elly Katabira, Dathan M. Byonanebye, Mohammed Lamorde, Rosalind Parkes-Ratanshi
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Introduction Evidence shows benefit of digital technology for people living with human immunodeficiency virus on antiretroviral therapy adherence and retention in care, however, scalability and sustainability have scarcely been evaluated. We
Externí odkaz:
https://doaj.org/article/cee32eb4fe60474586108427561cf75b
Autor:
Andrew Mujugira, Agnes Nakyanzi, Maria S. Nabaggala, Timothy R. Muwonge, Timothy Ssebuliba, Monica Bagaya, Olivia Nampewo, Oliver Sapiri, Kikulwe R. Nyanzi, Felix Bambia, Rogers Nsubuga, David M. Serwadda, Norma C Ware, Jared M. Baeten, Jessica E. Haberer
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 89(4)
HIV self-testing (HIVST) and pre-exposure prophylaxis (PrEP) are complementary tools that could empower sex workers to control their HIV protection, but few studies have jointly evaluated PrEP and HIVST in any setting.The Empower Study was an open-la
Autor:
Emily, Mabonga, Yukari C, Manabe, Ali, Elbireer, Joshua K, Mbazira, Maria S, Nabaggala, Agnes, Kiragga, Jennifer, Kisakye, Charlotte A, Gaydos, Chris, Taylor, Rosalind, Parkes-Ratanshi
Publikováno v:
Int J STD AIDS
The aim of this study was to establish the prevalence of asymptomatic Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) in key populations at increased risk of transmission of HIV. Additionally, we aimed to identify the associated risk factor
Autor:
Dathan Mirembe Byonanebye, Maria S Nabaggala, Agnes Bwanika Naggirinya, Mohammed Lamorde, Elizabeth Oseku, Rachel King, Noela Owarwo, Eva Laker, Richard Orama, Barbara Castelnuovo, Agnes Kiragga, Rosalind Parkes-Ratanshi
BACKGROUND Following the successful scale-up of antiretroviral therapy (ART), the focus is now on ensuring good quality of life (QoL) and sustained viral suppression in people living with HIV. The access to mobile technology in the most burdened coun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fe6d474c57bc4bf11967b6e0ea073ce
https://doi.org/10.2196/preprints.22229
https://doi.org/10.2196/preprints.22229